We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · July 22, 2020

Long-Term Outcomes of Rituximab Therapy in Pemphigus

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the European Academy of Dermatology and Venereology: JEADV
Long-Term Outcomes of Rituximab Therapy in Pemphigus
J Eur Acad Dermatol Venereol 2020 May 04;[EPub Ahead of Print], I Shimanovich, T Baumann, E Schmidt, D Zillikens, CM Hammers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading